TG Therapeutics (TGTX) Stock Forecast & Price Target

$23.94

-0.56 (-2.29%)

(As of 10/17/2024 ET)

TG Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 6 Analyst Ratings

Sell
0

Hold
1

Buy
5

Based on 6 Wall Street analysts who have issued ratings for TG Therapeutics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a hold rating, and 5 have given a buy rating for TGTX.

Consensus Price Target

$31.83
32.97% Upside

According to the 6 analysts' twelve-month price targets for TG Therapeutics, the average price target is $31.83. The highest price target for TGTX is $49.00, while the lowest price target for TGTX is $20.00. The average price target represents a forecasted upside of 32.97% from the current price of $23.94.

Get the Latest News and Ratings for TGTX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for TG Therapeutics and its competitors.

TGTX Analyst Ratings Over Time

Type	Current Forecast 10/18/23 to 10/17/24	1 Month Ago 9/18/23 to 9/17/24	3 Months Ago 7/20/23 to 7/19/24	1 Year Ago 10/18/22 to 10/18/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$31.83	$31.83	$29.83	$23.14
Forecasted Upside	32.97% Upside	26.93% Upside	42.06% Upside	238.35% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

The real reason Elon is fully endorsing Trump (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

TGTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TGTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

TG Therapeutics Stock vs. The Competition

Type	TG Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.83	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	32.97% Upside	13,672.28% Upside	6.34% Upside
News Sentiment Rating	Positive News See Recent TGTX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
9/18/2024	HC Wainwright 2 of 5 stars	Reiterated Rating	Buy ➝ Buy	$49.00 ➝ $49.00	+93.83%
8/7/2024	The Goldman Sachs Group 2 of 5 stars	Boost Target	Neutral ➝ Neutral	$18.00 ➝ $20.00	-5.03%
8/7/2024	B. Riley 4 of 5 stars	Boost Target	Buy ➝ Buy	$29.00 ➝ $34.00	+61.44%
5/2/2024	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$39.00 ➝ $40.00	+151.89%
4/18/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$25.00	+75.93%
11/1/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$23.00	+106.65%
Get the Latest News and Ratings for TGTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for TG Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
4/17/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight	$24.00	+16.90%
1/24/2023	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform	$16.00 ➝ $25.00	+89.54%
12/29/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Underperform	$5.00 ➝ $6.00	-40.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:56 PM ET.

TGTX Forecast - Frequently Asked Questions

: According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for TG Therapeutics is $31.83, with a high forecast of $49.00 and a low forecast of $20.00.
: 6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TG Therapeutics in the last year. There is currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TGTX shares.
: According to analysts, TG Therapeutics's stock has a predicted upside of 32.97% based on their 12-month stock forecasts.
: TG Therapeutics has been rated by research analysts at B. Riley, HC Wainwright, and The Goldman Sachs Group in the past 90 days.
: Analysts like TG Therapeutics more than other "medical" companies. The consensus rating score for TG Therapeutics is 2.83 while the average consensus rating score for "medical" companies is 2.79. Learn more on how TGTX compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Here’s how to start a “Weekend Side Hustle” from your sofa (Ad)

Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand. And that’s how you can kickstart your very own “Weekend Side Hustle!” Now that you know that…

Let me show you how I target extra income as early as THIS weekend!

This page (NASDAQ:TGTX) was last updated on 10/17/2024 by MarketBeat.com Staff

From Our Partners